Glimepiride

From WikiMD's Wellnesspedia

(Redirected from Amaryl)

Glimepiride is an oral blood glucose-lowering drug of the sulfonylurea class, used primarily for the management of type 2 diabetes. It is marketed under various trade names, including Amaryl. Glimepiride acts by increasing the amount of insulin released by the pancreas, which in turn lowers blood glucose levels. It is used in conjunction with diet, exercise, and sometimes other medications to manage blood sugar levels in people with type 2 diabetes.

Mechanism of Action[edit | edit source]

Glimepiride works by stimulating the release of insulin from the pancreatic beta cells. It achieves this by closing potassium channels in the beta cell membrane, which leads to cell depolarization and the opening of calcium channels. The influx of calcium then triggers the exocytosis of insulin-containing granules. The drug's action is glucose-dependent, meaning it becomes more active as blood sugar levels rise, thereby reducing the risk of hypoglycemia (low blood sugar levels).

Pharmacokinetics[edit | edit source]

After oral administration, glimepiride is completely absorbed from the gastrointestinal tract. Food does not significantly affect its absorption. It has a high protein binding rate (over 99%) and is extensively metabolized in the liver to two main metabolites. The elimination half-life of glimepiride is approximately 5 to 8 hours. Its metabolites are excreted in both urine and feces.

Indications[edit | edit source]

Glimepiride is indicated for the control of blood sugar in people with type 2 diabetes when diet, exercise, and other medications do not adequately control their blood sugar levels. It may be used alone or with other antidiabetic medications.

Contraindications[edit | edit source]

Glimepiride is contraindicated in patients with a history of hypersensitivity to it or any other sulfonylurea drugs. It should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. It is also contraindicated in patients with severe renal or hepatic impairment.

Side Effects[edit | edit source]

The most common side effects of glimepiride include hypoglycemia, nausea, headache, and dizziness. Other possible side effects are weight gain, allergic reactions, and changes in blood counts. Severe hypoglycemia can be life-threatening and requires immediate medical attention.

Drug Interactions[edit | edit source]

Glimepiride can interact with a number of other medications, which can either potentiate its hypoglycemic effect or reduce it. Drugs that may increase the risk of hypoglycemia when taken with glimepiride include nonsteroidal anti-inflammatory drugs (NSAIDs), certain antifungals, and other antidiabetic drugs. Conversely, certain drugs like corticosteroids and thyroid hormones may decrease its efficacy.

Precautions[edit | edit source]

Patients taking glimepiride should be aware of the signs and symptoms of hypoglycemia and should carry a source of sugar with them at all times. Regular monitoring of blood glucose levels is essential. Liver and kidney function should also be monitored regularly.

Dosage and Administration[edit | edit source]

The dosage of glimepiride is individualized based on the patient's needs and the desired blood glucose levels. It is typically started at a low dose to minimize the risk of hypoglycemia, with adjustments made based on the patient's response. Glimepiride is usually taken once daily with breakfast or the first main meal of the day.

Conclusion[edit | edit source]

Glimepiride is an effective medication for the management of type 2 diabetes, particularly when used as part of a comprehensive treatment plan including diet and exercise. However, it requires careful monitoring and adherence to dosing instructions to minimize the risk of side effects, especially hypoglycemia.


Resources[edit source]

Latest articles - Glimepiride

PubMed
Clinical trials
UpToDate

AI tools[edit source]

Generative AI tools and links to learn more on Glimepiride: ChatGPT - Bing Chat - Google Gemini. (caution advised).


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD